2. Implications of the Second Circuit's Equal Protection Analysis
The Second Circuit took pains to give its ruling a more moderate veneer
than that of its sister court. The court expressly rejected any
substantive due process right to assisted suicide, 80 F.3d at 723-25;
determined that the equal protection claim would be judged under the
less exacting standard of rational basis scrutiny, id. at 727;
intimated that the right to assisted suicide would not authorize a
physician to inject a lethal dosage into a patient incapable of
self-administering the dosage, id at 730 n.3; said nothing
about the right of a surrogate decision maker to request suicide
assistance on behalf of an incapacitated patient; and limited the
terms of its holding to patients in the final stages of terminal
illness, id. at 731.
In fact, however, it may well be that the Second Circuit's ruling
creates an even more expansive right to assisted suicide than does
the Ninth Circuit's. That is because of a basic difference between the
respective judicial inquiries under the due process and equal
protection clauses.
As the Ninth Circuit pointed out, the due process constitutional claim
of a patient seeking suicide assistance will be determined, like all
substantive due process claims, by weighing the strength of the various
competing interests present in any given circumstance. The court's
calibration of those competing interests led it to its bottom line
determination: "The liberty interest at issue here...in the case of the
terminally ill, is at its peak. Conversely, the state interests, while
equally important in the abstract, are for the most part at a low point
here." 79 F.3d at 837. While Agudath Israel believes, as elaborated
infra, that the Ninth Circuit incorrectly undervalued the state's
interest in preserving the life of even terminally ill persons there is
at least some room for argument that the due process balancing framework
will enable courts, in cases involving non-terminal patients where the
balance of competing interests tips in favor of the state, to draw the
line: "So far down the slope, but no farther." The equal protection
framework embraced by the Second Circuit, in contrast, would appear to
include no such line-drawing braking mechanism.
The relevant equal protection inquiry here is not how strong the state's
interest is in preserving life in any given context, but whether treating
"similarly circumstanced" persons differently is rationally related to a
legitimate state interest. As the Court stated in Hooper v. Bernalillo
County Assessor, 472 U.S. 612 (1985): "When a state distributes benefits
unequally, the distinctions it makes are subject to scrutiny under the
Equal Protection Clause of the Fourteenth Amendment. Generally, a law will
survive that scrutiny if the distinction rationally furthers a
legitimate state purpose." Id. at 618 (footnote omitted; emphasis
added). Accordingly, once one accepts the Second Circuit's conclusion that
a patient who seeks termination of life support and a patient who seeks
poison are "similarly circumstanced persons" who must be treated identically
unless the state can demonstrate that treating them differently rationally
advances a legitimate state interest, 80 F.3d at 729; and once one accepts
the court's additional conclusion that no such rational basis of distinction
exists when the two persons are in the final stages of terminal illness, id.
at 730-31 -- there is no readily apparent logical way of drawing lines
anywhere along the slope.
In reaching its holding that the prohibition against assisted suicide, as
applied to final-stage terminally ill patients, violates the equal protection
clause, the Second Circuit posed a series of dramatic questions, and an equally
dramatic answer:
"But what interest can the state possibly have in requiring
the prolongation of a life that is all but ended? Surely, the
state's interest lessens as the potential for life diminishes...
And what business is it of the state to require the continuation
of agony when the result is imminent and inevitable? What
concern prompts the state to interfere with a mentally competent
patient's 'right to define [his] own concept of existence, of
meaning, of the universe, and of the mystery of human life'
[citation omitted], when the patient seeks to have drugs
prescribed to end life during the final stages of a terminal
illness? The greatly reduced interest of the state in preserving
life compels the answer to these questions: 'None.'" 80 F.3d at
729-30.
|
The questions are indeed dramatic, and so is the response -- but they are also
highly misleading. For they imply that the equal protection analysis would be
different in cases where the state's interest in preserving life would be stronger
than the Second Circuit deems it to be at the final stages of terminal illness.
In fact, however, since the relevant inquiry is not whether the state has a
rational basis to preserve life, but whether it has a rational basis to
distinguish between patients who refuse life support and patients who
seek the means to commit suicide, it should make no equal protection difference
whatsoever how far along the patient's terminal illness has progressed, or even
whether he is terminally ill altogether. The strength of the state's interest
in preserving life is simply not relevant to the equal protection inquiry, for
it does not speak to any distinction the law might draw between the two
patients "similarly circumstanced."
The implication of the Second Circuit's ruling, therefore, is that wherever
the law permits an individual to forgo life support, equal protection demands that
it also permit him to request a lethal prescription. The Second Circuit's
apparent moderation is only skin deep; beneath its deceptively mild surface
lies constitutional radicalism.
Consider the body of New York law implicated most directly by the ruling below.
The right of competent persons to decline or discontinue life-sustaining medical
intervention was first established at common law in Schloendorf v. Society of
New York Hospital, 211 N.Y. 125, 129 (1914), where Judge Cardozo enunciated
the basic doctrine of personal autonomy in medical decision-making: "[E]very
human being of adult years and sound mind has a right to determine what shall
be done with his body; and a surgeon who performs an operation without his
patient's consent commits an assault, for which he is liable in damages." In
re Storar, 52 N.Y. 363, 376-77, cert. denied, 454 U.S. 858 (1981),
makes clear that the common law right of personal autonomy includes the right
to refuse treatment necessary to preserve one's life. The New York courts
have not limited such right to patients who are terminally ill -- certainly
not to patients who are in the final stages of their terminal illness. Given
the Second Circuit's rejection of any distinction between refusing life
support and requesting poison, if a young patient with a good prognosis for
recovery enjoys the common law right to refuse a life-saving operation, should
he not also enjoy the right to a lethal prescription?
The same question will apply when a third party is legally authorized to make
a decision on an incapacitated patient's behalf. Under New York common law,
"the right to decline treatment is personal and...could not be exercised by
a third party when the patient is unable to do so" unless there is "clear
and convincing evidence" that the incapacitated patient would have refused
life support. Matter of Westchester County Medical Center, 72 N.Y. 2d
517, 528-29 (1988). New York's legislature, however, has started moving away
from the "clear and convincing evidence" standard. Most notably, in 1990, a
statute was enacted empowering a duly designated health care agent to make
virtually any life-and-death treatment decision on behalf of his incapacitated
principal, irrespective of the principal's medical condition or prognosis.
Such decisions are to be made on the basis of the principal's wishes; or,
where the principal's wishes "are not reasonably known and cannot with
reasonable diligence be ascertained," on the basis of the principal's
"best interests." N.Y. Public Health Law § 2982 (McKinney's 1993).
Indeed, the state legislature has been considering proposed new legislation
developed by the New York State Task Force on Life and the Law, introduced in
the 1995-96 legislative session as S. 5020 / A.6791, which would empower
surrogates -- third parties appointed by the law, not by the patient
-- to make decisions under certain medical circumstances to refuse
life-sustaining treatment where the patient's "best interests" would be so
served. The Second Circuit's equal protection analysis, it would seem,
should empower such agents or third party surrogates to ask that the patient
be provided with poison as well, so long as they deem it to be in the patient's
"best interests."
There is yet one other noteworthy aspect of New York law: the legal obligation
of an individual health care provider to carry out the instructions of patients
and their duly appointed health care agents; or, if doing so would violate the
provider's religious beliefs or sincerely held moral convictions, to cooperate
in facilitating transfer of the patient to another medical practitioner who is
prepared to carry out such wishes. N.Y. Public Health Law § 2984 (McKinney's
1993). If a doctor has religious beliefs or moral convictions that preclude
him from helping the patient commit suicide, would not the Second Circuit's
equal protection analysis require his cooperation in transferring the patient
to a doctor who has no such qualms?
New York is not atypical in its recognition of a patient's right to decline
life-sustaining interventions, either personally or through an agent or
surrogate; if anything, New York's common law takes a harder line than most
other states in insisting on clear and convincing evidence of an incapacitated
patient's wishes. See Cruzan v. Director, Missouri Dept. of Health,
supra, 497 U.S. at 270-77. If the Second Circuit's ruling is permitted to
stand, its impact will be widespread, profound -- and, in our view,
devastating.